Journal
LUPUS
Volume 19, Issue 9, Pages 1020-1028Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/0961203310370046
Keywords
anti-Ro antibodies; autoantibody; autoantigen; B cells; complement; cutaneous lupus erythematosus; CXCL10; CXCR3; dendritic cells; genes; genetics; histology; IFN alpha; IL-18; immune complex; interferon; IP-10; keratinocyte; pathogenesis; photosensitivity; TLR; TNF alpha; Toll-like receptor; TREX1; UV light
Categories
Funding
- Deutsche Forschungsgemeinschaft DFG [WE 4428/1-1]
Ask authors/readers for more resources
The term 'cutaneous lupus erythematosus' (CLE) comprises several related autoimmune skin disorders, defined as 'specific' skin manifestations of lupus erythematosus (LE). The spectrum of clinical presentation of CLE is wide, reaching from mild erythema to disseminated scarring skin lesions. There is increasing knowledge concerning the pathogenesis of LE skin lesions and it has been shown that a complex network of cutaneous cytokines, chemokines and adhesion molecules orchestrate and promote tissue injury observed in LE skin lesions. However, a complete understanding of the diverse pathophysiological mechanisms in the different CLE subsets does not exist. Here we review the main pathological features described in CLE patients against the background of the clinical diversity of different CLE subtypes. Lupus (2010) 19, 1020-1028.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available